InvestorsHub Logo
Followers 29
Posts 2331
Boards Moderated 0
Alias Born 12/31/2004

Re: None

Tuesday, 06/13/2023 7:26:44 AM

Tuesday, June 13, 2023 7:26:44 AM

Post# of 22
iFabric Corp Announces Issuance of New United States Utility Patent for Antiviral Applications on Textiles
6/13/2023
MARKHAM, ON / ACCESSWIRE / June 13, 2023 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), today announced that its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has been granted a utility patent by the United States Patent and Trademark Office, in respect of an Antiviral Composition for textile use, predicated on the company's innovative PROTX2 AV Anti-bacterial and Anti-viral technology.

"The granting of this new US patent proves once again the innovative strength of IFTNA and, in particular our PROTX2 range of technologies. Specifically, the patent protects the use of PROTX2 AV in imparting anti-viral properties to any textile," stated Giancarlo Beevis, President and CEO of IFTNA.

"This patent grant is another important milestone, as we continue to move forward with the commercialization of PROTX2 treated products in the medical, hospitality, travel, and consumer markets," concluded Mr. Beevis.

ABOUT ProTX2

ProTX2® is a powerful eco-friendly technology that provides antibacterial, antimicrobial, antimold, anti-mildew, and anti-odor protection. When treated, each textile fiber is fundamentally transformed through PROTX2®'s technology, providing proprietary unrivaled protection against pathogens associated with healthcare-associated infections as well as the toughest odors, for medical and performance textiles.
https://finance.yahoo.com/news/ifabric-corp-announces-issuance-united-103000578.html